Treatment type: Cell therapies
-
Can cord-blood stem cells prevent brain damage in preterm babies?
Newborn health specialists from Hudson Institute of Medical Research are working with colleagues at Monash University and Monash Health on a potentially game-changing treatment for brain injuries in preterm babies using stem cells from cord blood donated by families after the birth of a full-term baby.… Read more
-
Hudson AI & epigenetics expert named CoLab Future Leaders Fellow
Dr Claire Sun from Hudson Institute of Medical Research has been awarded a prestigious Children’s Cancer CoLab Mid-Career Researcher Future Leader Fellowship.… Read more
-
Fulbright Scholarship to support UCB therapy trial for preterm babies
Neonatologist and clinician-scientist Associate Professor Atul Malhotra from The Ritchie Centre, the School of Clinical Sciences at Monash Health, and Monash Children’s Hospital, has been awarded a Fulbright Professional Coral Sea Scholarship to support the US implementation of an umbilical cord blood (UCB) cell therapies clinical trial for extremely preterm babies. … Read more
-
Hudson Cell Therapies facilitates Australian first UCB stem cell treatment for cerebral palsy
For the first time in Australia, a child has received an infusion of their own umbilical cord blood stem cells to treat cerebral palsy (CP), and Hudson Cell Therapies played a crucial role in making it happen. The therapy, not yet approved as a standard treatment for CP anywhere in the world, was administered to… Read more
-
Extracellular vesicles: A promising frontier in treating preterm brain injury
Despite advances in neonatal care, effective treatments for brain injury in premature babies remain a significant unmet need. Researchers at Hudson Institute of Medical Research, working with the School of Clinical Sciences at Monash Health, are tackling this challenge head-on with an innovative approach: engineered extracellular vesicles.… Read more
-
Breakthrough IBD treatment heads into clinical trials
People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most difficult to treat conditions associated with the disease.… Read more
-
Stem Cells: Hope on the horizon for preterm babies
Pioneering Australian research, undertaken by a collaboration of Monash Health’s Monash Children’s Hospital, The School of Clinical Sciences at Monash University, and Hudson Institute of Medical Research, has successfully demonstrated the feasibility and safety of using a baby’s own cord blood-derived cells as a potential treatment for extremely preterm infants.… Read more
-
Uncovering the cellular secrets of RNA editing
Professor Carl Walkley heads the RNA Biology and Innate Immune Sensing Research Group at Hudson Institute of Medical Research and their latest research, published in Science Immunology, sheds new light on these crucial processes.… Read more
-
New treatment hope for perinatal lung and brain injury
Hudson Institute researchers are lifting the lid on a treatment promising the benefits of stem cells but none of the drawbacks, offering potential to reduce the lifelong impacts of perinatal lung and brain injuries.… Read more
-
Grant to improve understanding of UCB stem cell treatment
Dr Tayla Penny will receive a grant of more than $96,000 from the Cerebral Palsy Alliance to advance her work on improving understanding of umbilical cord blood (UCB) stem cell treatment for perinatal brain injury.… Read more
